Semax 5mg

Semax in brain-response research

Semax 5mg contains the seven-amino-acid sequence MEHFPGP. The peptide combines an ACTH-derived segment with Pro-Gly-Pro and has been investigated for its influence on molecular and functional responses in the nervous system.

Studying the response to ischaemia

Cerebral ischaemia is a reduction in blood supply to the brain. Researchers have used rat models and RNA sequencing to examine how Semax affects the pattern of genes altered after ischaemic injury. This approach looks beyond a single biomarker to understand coordinated cellular responses.

Related work on BDNF and TrkB in the rat hippocampus provides another perspective, connecting the peptide with pathways involved in neuronal plasticity. These experiments form a mechanistic basis for further study rather than a direct demonstration of human neuroprotection.

Clinical research context

Human reports have investigated Semax during recovery after ischaemic stroke, using outcomes such as motor performance, the Barthel index of daily function and circulating BDNF. Reported improvements are relevant to that clinical setting; the study designs and populations limit extrapolation to memory or focus in healthy people.

Semax 5mg and 10mg share the same molecular research background. Their different supplied quantities do not create separate evidence for clinical effectiveness.

Also known as / branded as

• ACTH(4-7)-Pro-Gly-Pro
• ACTH(4-7)PGP
• Met-Glu-His-Phe-Pro-Gly-Pro
• MEHFPGP